ROSE M ROMAN TORRES

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism MAYAGUEZ, PR NPI 1124433909

General Payments — all program years on this page

$7,229.97

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 259
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $254.63 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $254.6313

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $177.139
Boehringer Ingelheim Pharmaceuticals, Inc. $55.503
Amgen Inc. $22.001

By program year

Program yearAmountRecords
2018 $1,007.6231
2019 $1,028.6646
2020 $1,581.8031
2021 $1,095.9645
2022 $1,335.5055
2023 $925.8038
2024 $254.6313

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104401241 AstraZeneca Pharmaceuticals LP $20.14 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104419375 AstraZeneca Pharmaceuticals LP $20.32 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104562114 AstraZeneca Pharmaceuticals LP $19.07 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104570172 AstraZeneca Pharmaceuticals LP $20.49 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104657777 AstraZeneca Pharmaceuticals LP $16.80 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105217042 AstraZeneca Pharmaceuticals LP $19.65 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105472265 AstraZeneca Pharmaceuticals LP $17.64 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105721460 AstraZeneca Pharmaceuticals LP $19.67 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105739506 AstraZeneca Pharmaceuticals LP $23.35 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116065916 Amgen Inc. $22.00 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117882838 Boehringer Ingelheim Pharmaceuticals, Inc. $14.57 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117882840 Boehringer Ingelheim Pharmaceuticals, Inc. $19.90 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117882842 Boehringer Ingelheim Pharmaceuticals, Inc. $21.03 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.